As of 2021, 1.7 million adults in the United States were living with type 1 diabetes, according to statistics from the CDC.

A dozen volunteers with severe type 1 diabetes showed clear improvements in their condition 12 months after receiving a ...

A Canadian nurse has kicked insulin to the curb after just one dose of an experimental stem cell therapy, with experts ...

Lydian Cosmetic Clinic has announced their advanced stem cell rejuvenation and scar reduction laser treatments for clients in ...

Sana is Incorporating the Tested Immune Evasion Technology to Develop SC451, a HIP-modified, Stem Cell-Derived Therapy as a One-Time Treatment for Patients with Type 1 Diabetes, with a Goal of Normal ...

D bioprinted nerve tissues offer new hope for ALS drug testing. Uppsala team creates motor neuron organoids from patient ...

Repositioning genes awakens fetal hemoglobin to treat disease. CRISPR editing may change future gene therapy. Researchers ...

The department has pledged it will meet an end-of-the-year deadline early for halting spinal cord injury research that used ...

More than 900 research grants worth $2.6 billion are in jeopardy. So is the 80-year-old model of American science.

Sanofi earns CHMP backing to expand Sarclisa's use for newly diagnosed multiple myeloma patients eligible for transplant.

Lundbeck today announces that orphan drug designation has been granted to Lu AG13909 by the US Food and Drug Administration (FDA) on 12 May 2025 and the European Medicines Agency (EMA) on 20 June 2025 ...